Skip to main content
. 2016 Jan 6;2016:5872423. doi: 10.1155/2016/5872423

Table 2.

Mean values and SD of clinical and laboratory parameters in relation to total assessments and nutritional status.

Parameter Total Eutrophic Overweight Obese p #
(n = 83) (n = 32) (n = 5)
Prescribed dose% (mg/day) 2.1 ± 1.3 2.0 ± 1.3 2.4 ± 1.3 2.1 ± 1.4 0.250
Adjusted dose%% (mg/Kg) 0.04 ± 0.03 0.05 ± 0.03 0.04 ± 0.02 0.03 ± 0.02 0.343
Time used (months) 25.9 ± 27.2 24.7 ± 27.6 29.0 ± 27.0 27.4 ± 24.9 0.369
Age (years) 13.0 ± 3.1 12.9 ± 2.9 13.5 ± 3.6 10.7 ± 3.1 0.176
Bone age (years) 13.0 ± 3.1 13.0 ± 3.1 13.3 ± 3.2 10.9 ± 3.0 0.305
WC (cm) 75.4 ± 11.5 70.8 ± 9.3 86 ± 9.0§ 84.5 ± 9.2 <0.001
SBP (mmHg) 102.5 ± 11.8 100.6 ± 10.3 106.6 ± 12.6§ 108 ± 21.7 0.080
DBP (mmHg) 63.5 ± 11.3 62.1 ± 11.1 67.5 ± 10.8§ 62 ± 14.8 0.078
Glycemia (mg/mL) 85.2 ± 8.5 84.2 ± 7.7 86.7 ± 8.5 93.6 ± 15.0 0.120
Insulin (nUI/mL) 9.4 ± 9.8 7.5 ± 8.3 14.2 ± 12.0§ 10.1 ± 8.1 0.003
HOMA-IR index 2.0 ± 2.3 1.6 ± 2.1 3.0 ± 2.5§ 2.5 ± 2.0 0.002
Total cholesterol (mg/dL) 156.2 ± 35.9 151.4 ± 31.2 164.0 ± 43.7 184.6 ± 40.7 0.096
LDL cholesterol (mg/dL) 87.5 ± 29.1 82.8 ± 26.2 96.4 ± 33.2§ 107.0 ± 31.1 0.045
HDL cholesterol (mg/dL) 52.7 ± 14.1 53.9 ± 14.9 48.7 ± 12.0 57.4 ± 5.9 0.119
Triglycerides (mg/dL) 80.3 ± 45.4 73.9 ± 38.6 93.5 ± 56.8 101.0 ± 55.7 0.081
AST (U/L) 23.4 ± 10.0 23.4 ± 10.9 22.8 ± 6.7 28.2 ± 12.4 0.475
ALT (U/L) 18.4 ± 16.9 16.5 ± 17.0 21.1 ± 11.8§ 31.4 ± 33.0 0.001
Leptin (pg/mL) 26.0 ± 16.4 19.2 ± 12.7 40.8 ± 13.6§ 44.3 ± 8.5 <0.001

WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure.

#Kruskal-Wallis test.

§Statistically significant difference (by Mann-Whitney test) between overweight and normal weight.

Statistically significant difference (by Mann-Whitney test) between obese and normal weight individuals (p = 0.05).

%Total prescribed risperidone.

%%Prescribed dose of risperidone, but adjusted per kg of body weight.